CO4920235A1 - Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado - Google Patents

Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado

Info

Publication number
CO4920235A1
CO4920235A1 CO97046477A CO97046477A CO4920235A1 CO 4920235 A1 CO4920235 A1 CO 4920235A1 CO 97046477 A CO97046477 A CO 97046477A CO 97046477 A CO97046477 A CO 97046477A CO 4920235 A1 CO4920235 A1 CO 4920235A1
Authority
CO
Colombia
Prior art keywords
composition
group
mixtures
amino acid
composition according
Prior art date
Application number
CO97046477A
Other languages
English (en)
Inventor
Nelson Sandra Lynn
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of CO4920235A1 publication Critical patent/CO4920235A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/20—Synthetic spices, flavouring agents or condiments
    • A23L27/21—Synthetic spices, flavouring agents or condiments containing amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se relaciona con una composiciónalimenticia, en bebida, farmacéutica o de tocador que comprende por lo menos un activo farmacéutico oralmente administrable que tenga un sabor indeseable tal como amargo, metálico o mezcla de ellos y un aminoácido fosforilado seleccionado del grupo consistente de fosfotirosina, fosfoserina, fosfotreonina y mezclas de ellos. Una composición de acuerdo con la reivindicación 1, en donde dicho alimento, bebida, producto farmacéutico o producto de tocador tiene un sabor indeseable seleccionado del grupo consistente de amargo, metálico y mezclas de ellos. Una composición de acuerdo con la reivindicación 1, en donde el activo farmacéutico es seleccionado del grupo consistente de descongestionantes, expectorantes, antitusivos, antihistamínicos, broncodilatadores, demulcentes, agentes antiinflamatorios, antipiréticos, analgésicos, anestésicos, antimicrobianos, antibióticos, peróxidos, antibacterianos, agentes anticálculo, agentes anticaries, nutrientes, antiácidos, antagonistas receptores-H2, laxantes, antidiarréicos, anorexiantes, anticolinérgicos, antinauseantes, y mezclas de ellos, Una composición de acuerdo con la reivindicación 1, en donde dicha composición es seleccionada del grupo consistente de una composición para el tratamiento de síntomas de tos/resfriado, un dentífrico, un enjugue bucal, y una composición para el tratamiento de molestias gastrointestinales.Una composición de acuerdo con la reivindicación 4, en donde dicha composición es una composición para el tratamiento de síntomas de tos/resfriado que comprende por lo menos un activo farmacéutico oralmente administrable que tiene un sabor indeseable seleccionado del grupo consistente de descongestionantes, expectorantes, antitusivos, antihistamínicos, broncodilatadores, demulcentes, agentes antiinflamatorios, antipiréticos, analgésicos, anestésicos, y mezclas de ellos y dicho aminoácido fosforilado es seleccionado del grupo consistente de fosfotirosina, fosfoserina, fosfotreonina, y mezclas de ellos. Una composición de acuerdo con la reivindicación 5, en donde dicho aminoácido fosforilado es fosfotirosina.
CO97046477A 1996-08-14 1997-08-13 Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado CO4920235A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/696,711 US5766622A (en) 1996-08-14 1996-08-14 Inhibiting undesirable taste in oral compositions

Publications (1)

Publication Number Publication Date
CO4920235A1 true CO4920235A1 (es) 2000-05-29

Family

ID=24798232

Family Applications (1)

Application Number Title Priority Date Filing Date
CO97046477A CO4920235A1 (es) 1996-08-14 1997-08-13 Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado

Country Status (21)

Country Link
US (1) US5766622A (es)
EP (1) EP1077726B1 (es)
JP (1) JP2001527518A (es)
KR (1) KR100323271B1 (es)
CN (1) CN1306440A (es)
AR (1) AR009079A1 (es)
AT (1) ATE234115T1 (es)
AU (1) AU724235B2 (es)
BR (1) BR9711159A (es)
CA (1) CA2263297C (es)
CO (1) CO4920235A1 (es)
CZ (1) CZ48199A3 (es)
DE (1) DE69719827T2 (es)
HU (1) HUP0103016A3 (es)
ID (1) ID19356A (es)
IL (1) IL128488A0 (es)
NO (1) NO990685L (es)
PE (1) PE100598A1 (es)
TR (1) TR199900300T2 (es)
WO (1) WO1998006436A2 (es)
ZA (1) ZA977082B (es)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6645988B2 (en) 1996-01-04 2003-11-11 Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US6699885B2 (en) * 1996-01-04 2004-03-02 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and methods of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
US6627233B1 (en) * 1997-09-18 2003-09-30 Wm. Wrigley Jr. Company Chewing gum containing physiological cooling agents
US6816934B2 (en) * 2000-12-22 2004-11-09 Hewlett-Packard Development Company, L.P. Computer system with registered peripheral component interconnect device for processing extended commands and attributes according to a registered peripheral component interconnect protocol
US6169118B1 (en) 1998-11-12 2001-01-02 Block Drug Company, Inc. Flavor blend for masking unpleasant taste of zinc compounds
US6326384B1 (en) 1999-08-26 2001-12-04 Robert R. Whittle Dry blend pharmaceutical unit dosage form
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
US6312723B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Pharmaceutical unit dosage form
US6780880B1 (en) 1999-08-26 2004-08-24 Robert R. Whittle FT-Raman spectroscopic measurement
US6262086B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Pharmaceutical unit dosage form
US6262085B1 (en) 1999-08-26 2001-07-17 Robert R. Whittle Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
US6312712B1 (en) 1999-08-26 2001-11-06 Robert R. Whittle Method of improving bioavailability
US6316020B1 (en) 1999-08-26 2001-11-13 Robert R. Whittle Pharmaceutical formulations
PE20020102A1 (es) * 2000-06-30 2002-03-06 Procter & Gamble Composicion topica oral que comprende un agente modulador de la respuesta del huesped frente a patogenos periodontales
US6391886B1 (en) * 2000-12-04 2002-05-21 The Procter & Gamble Company Oral compositions having improved consumer aesthetics
ITMI20012135A1 (it) * 2001-10-16 2003-04-16 Bioren S A Soluzioni iniettabili pronte all'uso di paracetamolo
US6887926B1 (en) 2001-11-16 2005-05-03 Oatey Co. Bonding compositions for chlorinated polymers and methods of using the same
US20040006111A1 (en) * 2002-01-25 2004-01-08 Kenneth Widder Transmucosal delivery of proton pump inhibitors
US7081264B2 (en) 2002-04-26 2006-07-25 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US6908637B2 (en) 2002-04-26 2005-06-21 Kraft Foods Holdings, Inc. Process for debittering peanut hearts
US20040091544A1 (en) * 2002-11-08 2004-05-13 Ruff Michael D. Coated dibasic calcium phosphate
CL2003002653A1 (es) * 2002-12-18 2005-04-22 Wyeth Corp Composicion farmaceutica que comprende (a) un antiinflamatorio no esteroidal (nsaid), preferentemente ibuprofeno, (b) un descongestionante, preferentemente pseudoefedrina y (c) un antihistaminico, preferentemente clorfeniramina; metodo para su prepar
EP1603537A4 (en) * 2003-02-20 2009-11-04 Santarus Inc IMMEDIATE RELEASE OF OMEPRAZOLE ANTACIDAL COMPLEX WITH NEW FORMULATION FOR RAPID AND PROLONGED ELIMINATION OF GASTRIC ACID
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
US20050084591A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Soups comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084600A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dips comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050238785A1 (en) * 2003-10-20 2005-10-27 Circle Group Holdings, Inc. Sauces comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084589A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Dressings comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20050084587A1 (en) * 2003-10-20 2005-04-21 Shukla Triveni P. Ice creams comprising emulsified liquid shortening compositions comprising dietary fiber gel, water and lipid
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
JP4435544B2 (ja) 2003-11-19 2010-03-17 高砂香料工業株式会社 果汁含有飲料
US20050137262A1 (en) * 2003-12-22 2005-06-23 Hu Patrick C. Highly concentrated pourable aqueous solutions of potassium ibuprofen, their preparation and their uses
EP1718164B1 (en) * 2004-02-26 2010-09-29 Wm. Wrigley Jr. Company Confections containing a blend of physilogical cooling agents
US8906940B2 (en) * 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US20050287275A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Sauces comprising dietary fiber gel
US20050287273A1 (en) * 2004-06-28 2005-12-29 Shukla Triveni P Processed cheeses comprising dietary fiber gel
US20060286268A1 (en) * 2005-06-14 2006-12-21 Circle Group Holdings, Inc. Amorphous insoluble cellulosic fiber and method for making same
WO2007100382A2 (en) * 2005-10-27 2007-09-07 Bernstein Lawrence R Orally administrable gallium compositions and method of use
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20090092658A1 (en) * 2007-10-05 2009-04-09 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8362083B2 (en) * 2008-01-15 2013-01-29 C.B. Fleet Company Inc. Taste-masked docusate compositions
EP2742350B1 (en) 2011-08-08 2019-10-30 The Coca-Cola Company Cell lines comprising endogenous taste receptors and their uses
US20160089439A1 (en) * 2014-09-28 2016-03-31 Satara Pharmaceuticals, LLC Prevention of Illicit Manufacutre of Methamphetamine from Pseudoephedrine Using Food Flavor Excipients
BR112022019696A2 (pt) * 2020-04-29 2022-11-22 Nestle Sa Produto nutricional contendo uma composição tampão e um aminoácido e métodos para uso de tal produto nutricional

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3140978A (en) * 1961-11-02 1964-07-14 Hoffmann La Roche Pharmaceutical composition containing complex magnesium aluminum silicate
US4031265A (en) * 1975-06-18 1977-06-21 The United States Of America As Represented By The Secretary Of Agriculture Method of reducing bitterness in citrus juices
US4248141A (en) * 1978-08-18 1981-02-03 Miller Jr Harry W Method and apparatus for debittering soybeans
CH635732A5 (fr) * 1979-01-26 1983-04-29 Nestle Sa Procede de desamerisation d'un extrait de fruits ou de legumes et extrait desamerise obtenu.
JPS56158707A (en) * 1980-04-08 1981-12-07 Lion Corp Composition for oral use
NZ199891A (en) * 1981-03-04 1985-07-31 Univ Melbourne Caries-inhibiting compositions containing casein or x-s-casein or phosuitin
US4517379A (en) * 1981-06-26 1985-05-14 Pfizer Inc. Branched amides of L-aspartyl-D-amino acid dipeptides
JPS59104310A (ja) * 1982-12-07 1984-06-16 Lion Corp 口腔用組成物
US4581232A (en) * 1983-07-20 1986-04-08 Warner-Lambert Company Magnesium trisilicate suitable for preparation of medicament adsorbates
US5286489A (en) * 1985-08-26 1994-02-15 The Procter & Gamble Company Taste masking compositions
US5015628A (en) * 1986-06-12 1991-05-14 The University Of Melbourne Anticariogenic phosphopeptides
US5192563A (en) * 1986-10-22 1993-03-09 Wm. Wrigley, Jr. Company Strongly mint-flavored chewing gums with reduced bitterness and harshness
US5009819A (en) * 1987-11-12 1991-04-23 The Liposome Company, Inc. Taste moderating composition
US5266717A (en) * 1989-04-03 1993-11-30 Glenn Roy N-(sulfomethyl)-N'arylureas
US4994490A (en) * 1989-04-03 1991-02-19 The Nutrasweet Company Novel N-(sulfomethyl)-N'-arylureas
JPH0354921A (ja) * 1989-07-24 1991-03-08 Nec Corp スケルチ信号発生回路
US5262179A (en) * 1989-09-13 1993-11-16 Nicholas Kiwi Pty Ltd. Non-effervescent ibuprofen compositions
JPH049335A (ja) * 1990-04-25 1992-01-14 Aamu:Kk ギムネマ・シルベスタの苦味・渋味除去方法およびその飲用物
US5232735A (en) * 1990-06-01 1993-08-03 Bioresearch, Inc. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers
US5024997A (en) * 1990-06-22 1991-06-18 American Home Products Corporation Palatable ibuprofen solutions
WO1992006991A1 (fr) * 1990-10-15 1992-04-30 Taisho Pharmaceutical Co., Ltd. Erythromycine modifiee en 2' ou derive de cette substance
JP3246738B2 (ja) * 1990-11-30 2002-01-15 ロート製薬株式会社 サポニン及びアミノ酸含有組成物
US5336513A (en) * 1991-02-20 1994-08-09 Kraft General Foods, Inc. Bitterness inhibitors
JPH0515389A (ja) * 1991-07-12 1993-01-26 Terumo Corp タンパク質様組成物の製造方法
DE4131118A1 (de) * 1991-09-19 1993-03-25 Henkel Kgaa Verfahren zur herstellung geschmacksneutraler pasten von alkylethersulfaten in glycerin
JPH0584288A (ja) * 1991-09-25 1993-04-06 Terumo Corp 創傷被覆材
JPH07504810A (ja) * 1991-11-27 1995-06-01 バイオリサーチ・インコーポレイテツド 特異的な可食物食味改質剤
DE4200821A1 (de) * 1992-01-15 1993-07-22 Bayer Ag Geschmacksmaskierte pharmazeutische mittel
JP2615345B2 (ja) * 1992-12-28 1997-05-28 三栄源エフ・エフ・アイ株式会社 呈味改善剤及び呈味改善方法
CN1065415C (zh) * 1993-02-05 2001-05-09 花王株式会社 蛋白质和类脂复合体用于改善味觉的用途
US5407921A (en) * 1993-07-01 1995-04-18 Kao Corporation Method for suppressing bitter taste

Also Published As

Publication number Publication date
BR9711159A (pt) 1999-08-17
DE69719827D1 (de) 2003-04-17
ATE234115T1 (de) 2003-03-15
NO990685L (no) 1999-04-12
CZ48199A3 (cs) 1999-06-16
IL128488A0 (en) 2000-01-31
CA2263297C (en) 2003-10-28
KR100323271B1 (ko) 2002-02-06
WO1998006436A2 (en) 1998-02-19
ID19356A (id) 1998-07-02
US5766622A (en) 1998-06-16
NO990685D0 (no) 1999-02-12
ZA977082B (en) 1998-03-04
EP1077726B1 (en) 2003-03-12
AU724235B2 (en) 2000-09-14
HUP0103016A2 (hu) 2001-12-28
AU3967697A (en) 1998-03-06
JP2001527518A (ja) 2001-12-25
WO1998006436A3 (en) 2000-12-21
KR20000030006A (ko) 2000-05-25
PE100598A1 (es) 1999-01-06
DE69719827T2 (de) 2003-12-24
EP1077726A2 (en) 2001-02-28
HUP0103016A3 (en) 2002-06-28
CN1306440A (zh) 2001-08-01
CA2263297A1 (en) 1998-02-19
AR009079A1 (es) 2000-03-08
TR199900300T2 (xx) 1999-06-21

Similar Documents

Publication Publication Date Title
CO4920235A1 (es) Metodo para inhibir el sabor indeseable en composiciones farmaceuticas y composiciones que tienen dicho sabor indeseable y un aminoacido fosforilado
AU727242B2 (en) Antimicrobial compositions
US6689399B1 (en) Transdermal delivery of an anti-inflammatory composition
CA2087146A1 (en) Flavour-masked pharmaceutical compositions
WO2003013428A3 (en) Nutritional supplements and methods of using same
EP1243274A3 (en) Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
DE122004000032I2 (de) Zusammensetzung die eine Tramadol-Verbindung und Acetaminophen enth{lt, und ihre Verwendung
JPH03501605A (ja) 痔疾並びにその他の治療用組成物
HUP0003547A2 (hu) Akut tüdőelváltozás és fibrózis kezelése alfavbéta6-antagonistákkal
US5541165A (en) Saliva substitute
US5908613A (en) Composition for the treatment and prevention of periodontal disease
US20020018773A1 (en) Gastric emptying-promoting composition
US6589513B2 (en) Oral hygiene formulation and method of use
CN111163762A (zh) 组合物在预防和/或***治疗诱发的口腔和胃肠粘膜炎中的用途
CN106265470A (zh) 益生菌发酵复方草本牙膏
US20080145461A1 (en) Formulation and method of making a topical pain relief composition
Suriamah et al. Effectiveness of toothpaste containing propolis, tea tree oil, and sodium monofluorophosphate against plaque and gingivitis
US5401728A (en) Lecithin based topical liniment
US20130243702A1 (en) Mouthwash Composition for Managing Oral Mucositis, Process and Methods Thereof
DE19502789A1 (de) Arzneimittel
CA2429793A1 (en) Interferon therapeutic effect enhancer
JPH0656677A (ja) 制酸剤組成物
EP1550443A4 (en) COMPOSITION AGAINST STRESS-BASED DISEASES
GR3034142T3 (en) Composition for the treatment or prevention of herpes
US20060216359A1 (en) Topical preparation for treating ulcerations on the inside of the month